Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 957 of 5804
-
New ointment aims to heal bedsores faster in diabetic patients
Disease control Not yet recruitingThis is a randomized, placebo-controlled, double-blind, 3-arm, single-center, phase IIa, parallel study to assess the efficacy, safety, and tolerability of topically applied 2.5%, 5% GM-XANTHO plus standard of care in patients with stage II or stage III pressure ulcer.
Phase: PHASE2 • Sponsor: Xantho Biotechnology Co., LTD • Aim: Disease control
Last updated Jun 26, 2026 12:54 UTC
-
App-Based doula support tested for rural First-Time mothers
Symptom relief Not yet recruitingThis study will assess the impact of virtual doula care on birth and postnatal outcomes among rural mothers. The goal of virtual doula services is to improve access to care in underserved communities and decrease urban-rural differences in key maternal health outcomes including m…
Phase: NA • Sponsor: RAND • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New brain scanner could sharpen epilepsy surgery targeting
Diagnosis Not yet recruitingThe success of epilepsy surgery depends largely on the reliability of the preoperative localization of the epileptogenic zone. The conventional method for determining the area to be removed is based on a complex assessment involving an electroencephalogram (EEG) coupled with simu…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New heart valve device tested in early trial
Disease control Recruiting nowAn evaluation of the ReValve System for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve surgery.
Phase: PHASE1 • Sponsor: ReValve Solutions Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Virus cocktail takes on stubborn diabetic foot infections
Disease control Not yet recruitingThe primary objective of this study is to compare the efficacy of standard treatment associated with a topical anti-staphylococcal bacteriophage cocktail versus standard treatment plus placebo for diabetic foot ulcers monoinfected by methicillin-resistant or susceptible S. aureus…
Phase: PHASE1, PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
One blood transfusion could prevent ventilator setbacks in ICU
Disease control Not yet recruitingIn comparison with a liberal transfusion strategy (high haemoglobin threshold), a restrictive transfusion strategy leads to around 50% decrease in the total number of transfused red blood cells (RBC) units and 30% to 40% fewer transfused patients, without any difference in mortal…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Engineered immune cells take on stomach cancer in early trial
Disease control Not yet recruitingThe goal of this clinical research study is to study the recommended dose of TROP2 CAR/IL-15 TGFBR2 KO NK cells that can be given intraperitoneally (infused directly into the stomach area) to participants with adenocarcinoma of the stomach that has spread to the peritoneum. The s…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug hopes to tame hardening skin disease
Disease control TerminatedThis study is designed to assess the safety and tolerability of the anti-human CCL24 monoclonal antibody CM-101 in adult patients with systemic sclerosis (SSc). Approximately 45 patients at approximately 40 sites will be randomized in a 2:1 ratio to receive either 10 mg/kg CM-101…
Phase: PHASE2 • Sponsor: ChemomAb Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Brain-Responsive device aims to quiet seizures
Disease control Not yet recruitingThis is a multicenter, prospective, controlled study designed to evaluate treatment with the BTS System.
Phase: NA • Sponsor: Cadence Neuroscience • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug may offer safer, faster fix for Post-Surgery heart flutter
Disease control Not yet recruitingPost-operative atrial fibrillation is a common problem post cardiac surgery with rates exceeding 30%. Atrial fibrillation has multiple adverse effects on cardiac hemodynamics and can lead to hypotension, diminished end organ perfusion and lengthen the stay in ICU. Amiodarone is t…
Phase: PHASE3 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for prostate cancer: drug combo aims to delay tumor growth
Disease control Not yet recruitingThis is a multi-center single arm phase II study of zanzalintinib after Pluvicto in chemotherapy-naïve mCRPC. Subjects will receive zanzalintinib 60mg orally (PO) once daily. Zanzalintinib may continue until evidence of radiographic progression, intolerable adverse events, or wit…
Phase: PHASE2 • Sponsor: Stuthi Perimbeti • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New CAR T-Cell therapy targets Hard-to-Treat myeloma
Disease control Not yet recruitingThe goal of this study is to evaluate the safety of a new type of CAR T-cell, UF-KURE-BCMA, for the treatment of patients with advanced multiple myeloma that has not responded to other therapies. The main question is whether the use of these new CAR T-cells is safe for patients w…
Phase: PHASE1 • Sponsor: Kure Cells, INC • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden sarcoma tumors in Children's lungs
Disease control Not yet recruitingSubjects will undergo infusion of 5 mg/kg indocyanine green, ICG ("TumorGlow") intravenously up to 5-days prior to surgery. Then, during the surgical procedure the next day, the subjects will undergo standard-of-care surgery. During the surgery, the fluorescence from the tumor wi…
Phase: EARLY_PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Simple exercises may boost nerve repair in diabetic neuropathy
Disease control Not yet recruitingThis study will examine how two types of exercise programs affect nerve health in people with diabetic peripheral neuropathy. Diabetic peripheral neuropathy is a common complication of type 2 diabetes that can cause numbness, pain, balance problems, and reduced quality of life. E…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Laser and 'Skin Booster' injection may reverse sun damage and prevent cancer
Disease control Not yet recruitingPhotodamaged skin increases the risk of skin cancer, highlighting the need for preventive treatments. Laser-assisted drug delivery (LADD) using ablative fractional lasers (AFL) enhances topical drug delivery and has proven safe and effective. Integrating non-invasive optical imag…
Phase: NA • Sponsor: Bispebjerg Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Nurse-Led mobile clinics aim to tame high blood pressure in liberia
Disease control Not yet recruitingThe goal of this study is to learn if a nurse-led, task-shifting, community-based program can help lower blood pressure in adults aged 25 and older with uncontrolled high blood pressure (hypertension) in Monrovia, Liberia. The program is delivered through community-based mobile c…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Virtual reality cartoons could replace needles for Kids' dental fear
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if virtual reality distraction can reduce dental anxiety and pain perception in children aged 6-10 years undergoing simple dental extraction. The main questions it aims to answer are: Does virtual reality distraction lower dental anxie…
Phase: NA • Sponsor: Sultan Qaboos University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
A personal guide to better heart health after pregnancy complications
Disease control Not yet recruitingThis study will examine whether a patient navigation program can help improve long-term heart health among people who experienced high blood pressure disorders during pregnancy at Boston Medical Center (BMC). Conditions such as preeclampsia and other hypertensive disorders of pre…
Phase: NA • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Ultrasound and blood markers may unlock personalized treatment for rare nerve disease
Knowledge-focused Not yet recruitingChronic inflammatory demyelinating polyradiculoneuritis (CIDP) is a rare autoimmune neuropathy characterized by significant clinical and therapeutic heterogeneity. Despite the availability of effective treatments, the response to intravenous immunoglobulins remains highly variabl…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can a smart drug deliver a toxic payload directly to cancer cells?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if ADC drug MC002 works to treat locally advanced/metastatic solid tumors in adults. It will also learn about the safety of MC002. The main questions it aims to answer are: Does participants tolerate the drug MC002 ? What medical probl…
Phase: PHASE1 • Sponsor: Hangzhou MacroLink Biopharmaceutical LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC